Pt-141 Dosage In Units

Direct Answer: Calculating PT-141 Dosage in Units for Laboratory Research

To determine the precise mass of Bremelanotide represented by syringe markings, researchers must apply volumetric conversion formulas tailored to the total reconstitution volume. On a standard U-100 insulin syringe, 100 volumetric units correspond to exactly 1.0 mL of liquid, meaning that a single unit mark represents 0.01 mL (10 microliters). When a 10 mg vial of high-purity PT-141 Bremelanotide is reconstituted with 2.0 mL of sterile diluent, the resulting solution yields a concentration of 5.0 mg/mL, or 50 micrograms (µg) per volumetric unit.

Conversely, if the same 10 mg vial is reconstituted using 1.0 mL of liquid, the concentration increases to 10.0 mg/mL, making each single unit on a U-100 micro-syringe equivalent to 100 µg of active peptide compound. Because syringe 'units' are pure measures of volume rather than biological activity or standardized mass, laboratory researchers must compute the exact microgram yield per unit for every unique dilution scheme before performing assay dosing or micro-injections in preclinical animal models.

Molecular Profile and Mechanism of Bremelanotide (PT-141)

PT-141, chemically designated as Bremelanotide, is a synthetic cyclic heptapeptide analog of naturally occurring alpha-melanocyte-stimulating hormone (α-MSH). Structurally derived from the central active core of Melanotan II, PT-141 possesses the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. The peptide features a cyclic lactam bridge between the aspartic acid and lysine residues, which imparts enhanced metabolic stability and enzymatic resistance compared to linear peptide sequences.

Pharmacologically, PT-141 acts as a non-selective agonist at central melanocortin receptors, displaying primary affinity for the MC3R and MC4R subtypes within the central nervous system. Unlike traditional vasoactive agents that target peripheral vascular cascades, preclinical investigations in our research library hub demonstrate that PT-141 operates via central neurochemical pathways. Binding to hypothalamic MC4R receptors triggers downstream signaling that regulates physiological functions linked to sexual-health pathways in rodent models, without activating peripheral adrenergic or dopaminergic receptors.

Mathematical Framework: Converting Mass (mg) to Volumetric Units

In analytical protocols, converting dry lyophilized peptide mass into syringe unit increments depends on the basic concentration equation $C = m / V$, where $C$ is final concentration, $m$ is total peptide mass in milligrams, and $V$ is total liquid volume in milliliters. Because laboratory equipment such as U-100 syringes divide 1.0 mL into 100 individual graduation marks, the volume per unit ($V_u$) is fixed at 0.01 mL.

To calculate the microgram payload per syringe unit ($D_u$), researchers use the formula: $D_u = (m / V) \times 10$, where $m$ is expressed in milligrams and $V$ in milliliters. For instance, dissolving a 10 mg lyophilized cake in 2.5 mL of solvent yields $C = 4.0\text{ mg/mL}$. Multiplying by 10 yields 40 µg per unit mark. Precision liquid handling requires calibrated micropipettes or micro-syringes to ensure that diluent volume is measured accurately, preserving dosage reproducibility across experimental runs.

Volumetric Unit Yields for 10 mg Reconstitution Protocols

To assist laboratory personnel in experimental design, the table below delineates the mathematical relationship between diluent volume, resulting concentration, and microgram yield per volumetric unit mark on a U-100 micro-syringe for a standard 10 mg vial of research-grade PT-141:

1. **1.0 mL Diluent Addition**: Generates a concentration of 10.0 mg/mL (10,000 µg/mL). Each volumetric unit on a U-100 syringe delivers exactly 100 µg of PT-141. A 5-unit measurement delivers 500 µg. 2. **2.0 mL Diluent Addition**: Generates a concentration of 5.0 mg/mL (5,000 µg/mL). Each volumetric unit on a U-100 syringe delivers exactly 50 µg of PT-141. A 10-unit measurement delivers 500 µg. 3. **2.5 mL Diluent Addition**: Generates a concentration of 4.0 mg/mL (4,000 µg/mL). Each volumetric unit on a U-100 syringe delivers exactly 40 µg of PT-141. A 25-unit measurement delivers 1,000 µg (1.0 mg). 4. **5.0 mL Diluent Addition**: Generates a concentration of 2.0 mg/mL (2,000 µg/mL). Each volumetric unit on a U-100 syringe delivers exactly 20 µg of PT-141. A 50-unit measurement delivers 1,000 µg (1.0 mg).

Selecting the appropriate dilution ratio depends on the required precision of the experimental assay. Higher dilution volumes (such as 2.5 mL or 5.0 mL) reduce measurement error when dispensing small microgram doses in animal research models.

Preclinical Research Findings: Melanocortin Receptor Activation

Preclinical evaluations of PT-141 have primarily focused on its central mechanism of action within hypothalamic nuclei. In rodent models, bilateral microinjections of Bremelanotide into the medial preoptic area (mPOA) and paraventricular nucleus (PVN) of the hypothalamus elicit robust responses associated with central melanocortin receptor activation. Radio-ligand binding assays demonstrate that PT-141 exhibits nanomolar affinity for MC4R ($K_i \approx 3.8\text{ nM}$) and MC3R ($K_i \approx 17\text{ nM}$), while displaying significantly reduced activity at MC1R compared to non-selective precursor peptides.

In vitro functional assays measuring intracellular cyclic adenosine monophosphate (cAMP) accumulation confirm that PT-141 acts as a potent full agonist at MC4R signaling cascades. These downstream signal transduction events recruit neural pathways involved in motivational and autonomic responses linked to sexual-health pathways in animal literature. Importantly, because PT-141 lacks the C-terminal basic amino acids required for potent MC1R binding, it exhibits minimal melanogenic stimulation in cutaneous cell models.

Comparative Analysis: PT-141 vs. Melanotan II and Melanotan I

When designing melanocortin signaling experiments, researchers frequently compare PT-141 against related synthetic melanocortins within the same structural class. The primary compounds evaluated alongside PT-141 include Melanotan II and Afamelanotide (Melanotan I). Each peptide displays distinct receptor selectivity profiles and physiological outputs in laboratory models:

While Melanotan II acts as a potent agonist across MC1R, MC3R, MC4R, and MC5R, its activation of peripheral MC1R receptors leads to significant melanogenesis (skin pigmentation) in preclinical models. PT-141 was specifically synthesized by truncating and modifying the terminal structures of Melanotan II to minimize MC1R cross-reactivity while preserving central MC3R/MC4R activation. Meanwhile, Melanotan I is a linear hexapeptide optimized strictly for selective MC1R agonism and melanogenesis. Consequently, PT-141 represents the primary pharmacological tool when researchers seek to isolate central nervous system melanocortin responses without confounding integumentary pigmentation artifacts.

Laboratory Reconstitution and Liquid Handling Protocols

Proper solubilization of lyophilized PT-141 is critical to ensure compound integrity, retain bioactivity, and prevent physical aggregation. Reconstitution should always take place under aseptic conditions within a laminar flow hood. Researchers should use high-purity bacteriostatic water containing 0.9% benzyl alcohol as a preservative when preparing multi-dose stock vials for extended benchtop studies, or sterile 0.9% sodium chloride for immediate single-use in vitro cell assays.

To reconstitute, sanitize the rubber septum of the vial with 70% isopropyl alcohol. Using a sterile syringe, draw the exact pre-calculated volume of diluent and slowly direct the stream down the inside glass wall of the vial. Direct impingement of liquid onto the delicate lyophilized cake can cause structural denaturation or mechanical shearing of the peptide sequence. Allow the diluent to passively saturate the powder, gently swirling the vial in a circular motion until fully dissolved. **Never shake or vortex** the vial, as mechanical agitation introduces air bubbles and promotes protein surface denaturation.

Storage Integrity and Degradation Kinetics

Lyophilized Bremelanotide exhibits excellent long-term thermal stability when stored under appropriate environmental controls. Unreconstituted vials supplied by PX1 Research should be stored at -20°C (-4°F) or -80°C (-112°F) for extended preservation, where the compound remains stable for up to 24 months. Protect lyophilized vials from direct light exposure by storing them in light-impermeable boxes or original foil packaging.

Once reconstituted into aqueous solution, peptide degradation kinetics accelerate. Reconstituted stock solutions prepared with bacteriostatic water should be refrigerated at 2°C to 8°C (36°F to 46°F) and utilized within 28 to 30 days. For long-term storage of reconstituted aliquots, researchers should divide the stock solution into single-use micro-tubes to prevent repeated freeze-thaw cycles, storing them at -80°C. Repeated freezing and thawing breaks cyclic peptide bonds and causes rapid loss of receptor-binding potency.

Quality Verification: RP-HPLC, Mass Spectrometry, and Endotoxin Limits

For laboratory findings to achieve peer-reviewed rigor, experimental reagents must meet rigorous analytical purity metrics. PX1 Research subjects every production lot of research peptides to comprehensive verification in ISO 17025 accredited analytical laboratories located within the United States.

Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a minimum purity threshold of >99.0%. Molecular identity is confirmed via Electrospray Ionization Mass Spectrometry (ESI-MS), matching the observed molecular weight against the theoretical mass of Bremelanotide (1024.2 g/mol). Furthermore, because bacterial contamination interferes with melanocortin receptor assays and cell viability studies, all lots undergo chromogenic LAL endotoxin testing (USP <85>), guaranteeing endotoxin levels strictly below <0.01 EU/mg. Batch-specific Certificates of Analysis (COAs) are published for complete lot traceability.

Procurement and Institutional Purchasing at PX1 Research

PX1 Research serves as a primary USA-manufactured supplier of high-purity research compounds for university laboratories, private research institutions, and biotech organizations. All products are synthesized under GMP-compliant facility standards to guarantee lot-to-lot consistency across long-term research initiatives.

Orders ship directly from distribution centers located in California and Arizona, providing same-day dispatch for orders placed Monday through Friday before cutoff times. Institutional buyers seeking bulk quantities or ongoing supply agreements for cell culture and preclinical trial series can apply for specialized pricing structures through our wholesale lab purchasing portal.